BioHealth News
Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network
Emmes, part of Emmes Group, today announced they will provide a Clinical Coordinating Center for the NIH's National Institute on Drug Abuse Clinical Trials…
Read More
BISNOW: Join the Leaders in Life Sciences and Real Estate at the International Life Sciences Real Estate Conference Next Week in Rockville
The International Life Sciences Real Estate Conference, taking place on September 11-12, 2024, at the Bethesda North Marriott Hotel & Conference Center in Rockville,…
Read More
Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15
GAITHERSBURG, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for…
Read More
BioHealth Capital Region Week is Just Two Weeks Away: Register Now!
As we approach the exciting BioHealth Capital Region Week, slated to kick off in just two weeks, there's still time to secure your spot…
Read More
Global Leadership in Clinical Research: A Conversation with Peter Ronco, CEO of Emmes
In this episode of BioTalk, Rich Bendis, President and CEO of BioHealth Innovation, Inc., sits down with Peter Ronco, Chief Executive Officer of Emmes,…
Read More
FDA approves Novavax’s 2024-2025 COVID-19 Vaccine
GAITHERSBURG, Md., Aug. 30, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced the Novavax COVID-19 Vaccine, Adjuvanted…
Read More
Activation Capital Selects 10 Startups for Inaugural Frontier BioHealth Program
RICHMOND, Va., Aug. 28, 2024 /PRNewswire/ -- Activation Capital, an innovation ecosystem development organization, has announced the selection of 10 fast-growing startups from across the country…
Read More
Arlington’s OxiWear Receives FDA Clearance as a Medical Device
ARLINGTON, Va., Aug. 28, 2024 /PRNewswire/ -- OxiWear, a pioneering company in wearable health technology, is proud to announce that it has received clearance from the…
Read More
TEDCO’s Pre-Seed Rural Business Innovation Initiative Invests in NEOPATHOLOGY CORP.
Rural Maryland-based biotechnology business seeks to develop new methods for image-based tissue diagnostics and assays COLUMBIA, Md., (August 27, 2024) — TEDCO, Maryland’s economic…
Read More
Johns Hopkins Technology Ventures Celebrates a Decade of Innovation with the Release of FY24 Annual Report
Johns Hopkins Technology Ventures (JHTV) has proudly released its FY24 Annual Report, marking ten years of exceptional growth in innovation and entrepreneurship. The report…
Read More
September 9th: HJF Networking and Educational Series
HJF, Montgomery County, Maryland & BioBuzz We are teaming up to bring the research community a new and exciting opportunity - the HJF Networking…
Read More
TEDCO Invests in Simmbion, LLC
COLUMBIA, Md., (August 26, 2024) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $200,000 Pre-Seed Builder Fund investment in Simmbion, LLC.…
Read More
Techstars, Johns Hopkins University, and CareFirst BlueCross BlueShield to Bring Healthcare AI Accelerator to Baltimore
BALTIMORE--(BUSINESS WIRE)--Techstars, Johns Hopkins University, and CareFirst BlueCross BlueShield (CareFirst) announced today a collaboration to launch a new healthcare accelerator program designed to support early-stage entrepreneurs building…
Read More
NIH SBIR Cycle is Opening: Deadline Approaching on January 5th, 2025
The next cycle of the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program is just around the corner, with a critical…
Read More
Meet the BHI Analyst Team at the BioHealth Capital Region Investment Conference
This September 19th, the BioHealth Capital Region Investment Conference will once again serve as a premier gathering for the biopharma sector, uniting a dynamic…
Read More